ZA885888B - Leukotriene antagonists - Google Patents

Leukotriene antagonists

Info

Publication number
ZA885888B
ZA885888B ZA885888A ZA885888A ZA885888B ZA 885888 B ZA885888 B ZA 885888B ZA 885888 A ZA885888 A ZA 885888A ZA 885888 A ZA885888 A ZA 885888A ZA 885888 B ZA885888 B ZA 885888B
Authority
ZA
South Africa
Prior art keywords
alkyl
formula
phenyl
hydrogen atom
group
Prior art date
Application number
ZA885888A
Other languages
English (en)
Inventor
Francis Patrick Carr
Patrick Carr Francis
Robert Delane Dillard
Delane Dillard Robert
Winston Stanley Marshall
Stanley Marshall Winston
Doris Elfriede Mccullough
Elfriede Mccullough Doris
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA885888B publication Critical patent/ZA885888B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA885888A 1987-08-14 1988-08-10 Leukotriene antagonists ZA885888B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/085,586 US4820722A (en) 1987-08-14 1987-08-14 Disubstituted tetrazoles and their use as leukotriene antagonists

Publications (1)

Publication Number Publication Date
ZA885888B true ZA885888B (en) 1990-04-25

Family

ID=22192620

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA885888A ZA885888B (en) 1987-08-14 1988-08-10 Leukotriene antagonists

Country Status (13)

Country Link
US (1) US4820722A (ko)
EP (1) EP0305085B1 (ko)
JP (1) JPS6466175A (ko)
KR (1) KR890003715A (ko)
CN (1) CN1013769B (ko)
AT (1) ATE92052T1 (ko)
AU (1) AU610629B2 (ko)
DE (1) DE3882619T2 (ko)
DK (1) DK449488A (ko)
HU (1) HUT50463A (ko)
NZ (1) NZ225793A (ko)
PT (1) PT88245B (ko)
ZA (1) ZA885888B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853398A (en) * 1987-04-13 1989-08-01 Eli Lilly And Company Leukotriene antagonists and use thereas
IL98405A0 (en) * 1990-06-11 1992-07-15 Fmc Corp Pharmaceutical compositions containing enzyme inhibiting agents
US5210208A (en) * 1990-09-24 1993-05-11 Rhone-Poulenc Rorer Pharmaceuticals Inc. Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity
DE4124942A1 (de) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661505A (en) * 1982-11-03 1987-04-28 Eli Lilly And Company Leukotriene antagonists
US5105017A (en) * 1983-07-18 1992-04-14 Eli Lilly And Company Leukotriene antagonist intermediates
PT85110A (en) * 1986-06-23 1987-07-01 Merck Frosst Canada Inc Process for preparing benzenealkanoic acid derivatives useful as leukotriene antagonists
US4820723A (en) * 1987-08-14 1989-04-11 Eli Lilly And Company Disubstituted tetrazole leukotriene antagonists and methods for their use thereas

Also Published As

Publication number Publication date
PT88245B (pt) 1995-03-01
HUT50463A (en) 1990-02-28
US4820722A (en) 1989-04-11
DK449488D0 (da) 1988-08-11
PT88245A (pt) 1989-06-30
CN1013769B (zh) 1991-09-04
DE3882619D1 (de) 1993-09-02
EP0305085B1 (en) 1993-07-28
CN1031223A (zh) 1989-02-22
EP0305085A1 (en) 1989-03-01
AU2096688A (en) 1989-02-16
DK449488A (da) 1989-03-17
AU610629B2 (en) 1991-05-23
JPS6466175A (en) 1989-03-13
NZ225793A (en) 1990-10-26
KR890003715A (ko) 1989-04-17
DE3882619T2 (de) 1993-12-23
ATE92052T1 (de) 1993-08-15

Similar Documents

Publication Publication Date Title
TNSN99171A1 (fr) 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
ES8401027A1 (es) Procedimiento para la obtencion de acidos 1-carboxi-(alcanoil o aralcanoil)-indolin-2-carboxilicos.
MA26877A1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
TW369521B (en) Androstenone derivative
FR2639636B1 (fr) Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
NO20015226L (no) Tri-aryl syrederivater som PPAR reseptor ligander, farmasoytisk sammensetning omfattende samme og anvendelse av samme for fremstilling av medikament.
NO943341D0 (no) Sammensetninger for orale preparater
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
FI940105A0 (fi) Menetelmä sertraliinivälituotteiden valmistamiseksi
GR3035414T3 (en) Novel imidazole derivatives, their preparation and therapeutic applications.
IL114241A0 (en) Thiazolidine derivatives their preparation and compositions containing them
ATE78812T1 (de) Diarylverbindungen als antiatherosklerotische mittel.
ATE196293T1 (de) Triazole enthaltende antifungizide mittel
ZA952614B (en) The use of carboxylic acid derivatives as drugs
ATE233246T1 (de) Hydantoinderivate als zwischenprodukte für pharmazeutische wirkstoffe
DE69526726D1 (de) Tetrasubstituierte imidazolderivate, verfahren zu ihrer herstellung, ihre anwendung als medikamente und diese enthaltende pharmazeutischen zusammensetzungen
ZA885888B (en) Leukotriene antagonists
FI964482A0 (fi) Amidijohdannaisia ja niiden käyttö lääkkeenä
CA2107485A1 (fr) Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2763592B1 (fr) Nouveaux derives glycosyles des ginkgolides, leur application en tant que medicaments et compositions pharmaceutiques les contenant
FI970434A0 (fi) Uudet 3-substituoidut 3H-2,3-bentsodiatsepiinijohdannaiset, niiden valmistus ja käyttö lääkkeenä
ATE40987T1 (de) Acetylenische phenoxypropanolderivate und pharmazeutische zusammensetzungen fuer die behandlung von bluthochdruck.
FR2363324A1 (fr) Solutions aqueuses ou hydroalcooliques stables d'essences parfumees ou de medicaments solubles dans l'huile
DE69512419D1 (de) IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-2-CARBONSÄURE DERIVATE, IHRE HERSTELLUNG UND SIE ENTHALTENDE ARZNEIMITTEL
ATE155791T1 (de) Etoposid-derivate, ihre herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels